NKTR - Nektar Therapeutics

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue165,436230,784200,707
Cost of Revenue30,21534,10228,533
Gross Profit135,221196,682172,174
Operating Expenses
Research Development203,801182,787147,734
Selling General and Administrative44,27543,26640,925
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-112,855-29,371-16,485
Income from Continuing Operations
Total Other Income/Expenses Net2,387-12,399814
Earnings Before Interest and Taxes-110,468-41,770-15,671
Interest Expense42,18038,90138,757
Income Before Tax-152,648-80,671-54,428
Income Tax Expense876506-512
Minority Interest---
Net Income From Continuing Ops-153,524-95,256-53,916
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-153,524-81,177-53,916
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-153,524-81,177-53,916